EMCORE Corporation to Host Fiscal 2024 Second Quarter Conference Call on May 8, 2024
May 02, 2024 16:03 ET
|
EMCORE Corporation
EMCORE Corporation to Host Fiscal 2024 Second Quarter Conference Call on May 8, 2024
Gevo Reports First Quarter 2024 Financial Results
May 02, 2024 16:01 ET
|
Gevo, Inc.
ENGLEWOOD, Colo., May 02, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the first quarter 2024 and recent...
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
May 02, 2024 16:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma announces first quarter 2024 results and provides corporate update
Complete Solaria to be Self-Funded in Q2 2024
May 02, 2024 14:30 ET
|
Complete Solaria Inc.
Complete Solaria reported earnings today and announced the Company will be self-funded in Q2 2024.
SuRo Capital Corp. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
May 02, 2024 13:00 ET
|
SuRo Capital Corp.
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”) (Nasdaq: SSSS) today announced that it will report its financial results for the quarter ended March 31, 2024 after the...
Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
May 02, 2024 09:15 ET
|
Virios Therapeutics
ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat...
Motorsport Games to Report First Quarter 2024 Financial Results
May 02, 2024 09:00 ET
|
Motorsport Games Inc.
Motorsport Games to is scheduled to report Q1 2024 financial results on May 7 2024 after market
Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
May 02, 2024 08:03 ET
|
Longeveron
Longeveron to report Q1 2024 financial results on May 14, 2024.
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
May 02, 2024 08:00 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...
Agios Reports Business Highlights and First Quarter 2024 Financial Results
May 02, 2024 07:00 ET
|
Agios Pharmaceuticals, Inc.
– Topline Data Readout from the Phase 3 ENERGIZE-T Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia now expected in Q2 2024 – – Announced Positive Results from the...